Department of Anaesthesiology, Ludwig-Maximilians-University, Munich, Germany.
PLoS One. 2013 May 7;8(5):e62741. doi: 10.1371/journal.pone.0062741. Print 2013.
Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypothesized that individuals with traumatic stress exposure and post-traumatic stress disorder (PTSD), an anxiety disorder characterized by the inappropriate persistence and uncontrolled retrieval of traumatic memories, show measurable alterations in plasma EC and NAE concentrations.
We determined plasma concentrations of the ECs anandamide (ANA) and 2-arachidonoylglycerol (2-AG) and the NAEs palmitoylethanolamide (PEA), oleoylethanolamide (OEA), stearoylethanolamine (SEA), and N-oleoyldopamine (OLDA) by HPLC-MS-MS in patients with PTSD (n = 10), trauma-exposed individuals without evidence of PTSD (n = 9) and in healthy control subjects (n = 29). PTSD was diagnosed according to DSM-IV criteria by administering the Clinician Administered PTSD Scale (CAPS), which also assesses traumatic events.
Individuals with PTSD showed significantly higher plasma concentrations of ANA (0.48 ± 0.11 vs. 0.36 ± 0.14 ng/ml, p = 0.01), 2-AG (8.93 ± 3.20 vs. 6.26±2.10 ng/ml, p<0.01), OEA (5.90 ± 2.10 vs. 3.88 ± 1.85 ng/ml, p<0.01), SEA (2.70 ± 3.37 vs. 0.83 ± 0.47, ng/ml, p<0.05) and significantly lower plasma levels of OLDA (0.12 ± 0.05 vs. 0.45 ± 0.59 ng/ml, p<0.05) than healthy controls. Moreover, PTSD patients had higher 2-AG plasma levels (8.93 ± 3.20 vs. 6.01 ± 1.32 ng/ml, p = 0.03) and also higher plasma concentrations of PEA (4.06 ± 1.87 vs. 2.63±1.34 ng/ml, p<0.05) than trauma-exposed individuals without evidence of PTSD. CAPS scores in trauma-exposed individuals with and without PTSD (n = 19) correlated positively with PEA (r = 0.55, p = 0.02) and negatively with OLDA plasma levels (r = -0.68, p<0.01). CAPS subscores for intrusions (r = -0.65, p<0.01), avoidance (r = -0.60, p<0.01) and hyperarousal (r = -0.66, p<0.01) were all negatively related to OLDA plasma concentrations.
PTSD appears to be associated with changes in plasma EC/NAE concentrations. This may have pathophysiological and diagnostic consequences but will need to be reproduced in larger cohorts.
内源性大麻素(ECs)和相关的 N-酰基乙醇酰胺(NAEs)在应激反应调节、焦虑和创伤记忆中发挥重要作用。鉴于人类在急性轻度应激条件下循环 EC 水平升高的证据,我们假设创伤暴露和创伤后应激障碍(PTSD)的个体,即表现为创伤记忆不适当持续和不受控制检索的焦虑障碍,表现出可测量的血浆 EC 和 NAE 浓度变化。
我们通过 HPLC-MS-MS 测定了 PTSD 患者(n=10)、有创伤暴露但无 PTSD 证据的个体(n=9)和健康对照受试者(n=29)的血浆中 EC 花生四烯酸酰胺(ANA)和 2-花生四烯酰甘油(2-AG)以及 NAE 棕榈酰乙醇酰胺(PEA)、油酰乙醇酰胺(OEA)、硬脂酰乙醇胺(SEA)和 N-油酰多巴胺(OLDA)的浓度。根据 DSM-IV 标准,通过使用临床医生管理的 PTSD 量表(CAPS)对 PTSD 进行诊断,该量表还评估了创伤事件。
与健康对照组相比,PTSD 患者的血浆 ANA(0.48±0.11 vs. 0.36±0.14ng/ml,p=0.01)、2-AG(8.93±3.20 vs. 6.26±2.10ng/ml,p<0.01)、OEA(5.90±2.10 vs. 3.88±1.85ng/ml,p<0.01)、SEA(2.70±3.37 vs. 0.83±0.47ng/ml,p<0.05)和 OLDA(0.12±0.05 vs. 0.45±0.59ng/ml,p<0.05)的血浆水平明显更高。此外,PTSD 患者的 2-AG 血浆水平(8.93±3.20 vs. 6.01±1.32ng/ml,p=0.03)和 PEA(4.06±1.87 vs. 2.63±1.34ng/ml,p<0.05)的血浆浓度也高于无 PTSD 证据的创伤暴露个体。有 PTSD 和无 PTSD 的创伤暴露个体(n=19)的 CAPS 评分与 PEA(r=0.55,p=0.02)呈正相关,与 OLDA 血浆水平(r=-0.68,p<0.01)呈负相关。CAPS 子评分的侵入(r=-0.65,p<0.01)、回避(r=-0.60,p<0.01)和警觉性增高(r=-0.66,p<0.01)均与 OLDA 血浆浓度呈负相关。
PTSD 似乎与血浆 EC/NAE 浓度的变化有关。这可能具有病理生理学和诊断意义,但需要在更大的队列中复制。